全文获取类型
收费全文 | 62900篇 |
免费 | 3832篇 |
国内免费 | 229篇 |
专业分类
耳鼻咽喉 | 748篇 |
儿科学 | 1440篇 |
妇产科学 | 1120篇 |
基础医学 | 8076篇 |
口腔科学 | 1285篇 |
临床医学 | 5984篇 |
内科学 | 13654篇 |
皮肤病学 | 884篇 |
神经病学 | 6368篇 |
特种医学 | 2543篇 |
外国民族医学 | 56篇 |
外科学 | 9984篇 |
综合类 | 578篇 |
一般理论 | 28篇 |
预防医学 | 4251篇 |
眼科学 | 1253篇 |
药学 | 3917篇 |
中国医学 | 77篇 |
肿瘤学 | 4715篇 |
出版年
2023年 | 289篇 |
2022年 | 586篇 |
2021年 | 1266篇 |
2020年 | 771篇 |
2019年 | 1257篇 |
2018年 | 1515篇 |
2017年 | 1099篇 |
2016年 | 1159篇 |
2015年 | 1454篇 |
2014年 | 2064篇 |
2013年 | 2881篇 |
2012年 | 4233篇 |
2011年 | 4490篇 |
2010年 | 2513篇 |
2009年 | 2395篇 |
2008年 | 3997篇 |
2007年 | 4253篇 |
2006年 | 3998篇 |
2005年 | 3934篇 |
2004年 | 3641篇 |
2003年 | 3414篇 |
2002年 | 3178篇 |
2001年 | 667篇 |
2000年 | 506篇 |
1999年 | 592篇 |
1998年 | 699篇 |
1997年 | 609篇 |
1996年 | 478篇 |
1995年 | 465篇 |
1994年 | 393篇 |
1993年 | 386篇 |
1992年 | 316篇 |
1991年 | 312篇 |
1990年 | 268篇 |
1989年 | 268篇 |
1988年 | 248篇 |
1987年 | 248篇 |
1986年 | 229篇 |
1985年 | 243篇 |
1984年 | 305篇 |
1983年 | 277篇 |
1982年 | 312篇 |
1981年 | 287篇 |
1980年 | 257篇 |
1979年 | 203篇 |
1978年 | 189篇 |
1977年 | 132篇 |
1976年 | 163篇 |
1975年 | 150篇 |
1974年 | 174篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
Sajeel Chowdhary MD Lisa M. Chalmers PA-C Marc Chamberlain MD 《Journal of neuroimaging》2007,17(1):69-73
In the course of 1 year at a tertiary cancer center, 3 patients (2 men; 1 woman; age 51-75 years) were seen in neurological consultation (1.5% of all consultations). Clinical course in all patients was of a progressive neurologic disorder not consistent with either a primary or secondary malignancy. Magnetic resonance (MR) imaging was most informative with respect to diagnosis and subsequent management. Brain biopsy was performed in all patients to assist in both diagnosis and prognostication. All patients were determined to have progressive multifocal leukoencephalopathy (PML) by brain biopsy. 相似文献
72.
73.
74.
Clemens Aigner Peter Jaksch Samy Mazhar Kriztina Czebe Gabriel Marta Sharokh Taghavi Georg Lang Walter Klepetko 《European journal of cardio-thoracic surgery》2004,25(2):184-187
OBJECTIVES: The use of OKT3 for treatment of advanced high-grade acute rejection episodes eventually can result in cytokine release and consecutive pulmonary edema. Temporary extracorporeal membrane oxygenation (ECMO) bridging can be used to overcome this crucial period before the beneficial effects of OKT3 can be observed. METHODS: We summarize our experience with three patients, who underwent lung transplantation and presented with severe acute rejection episodes. OKT3 had to be initiated due to insufficient response to standard rejection therapy with corticosteroids. Upon initiation of OKT3 treatment, a massive life-threatening deterioration of lung function in spite of heavily invasive respirator treatment was seen and temporary ECMO support was imperative to support graft function. Results of this treatment were retrospectively reviewed. RESULTS: In all cases femoro-femoral veno-arterial ECMO was used for support of the impaired graft and after a period of 4-5 days led to a massive improvement of graft function. In the further course two patients could be discharged from hospital and are still alive 30 and 36 months, respectively, after the described incident. One patient died 4 months later due to liver failure. CONCLUSIONS: We conclude that the use of ECMO support in patients experiencing significant side effects from OKT3 therapy is a useful and effective therapeutic tool to overcome the initial critical period until the lung has sufficiently recovered. 相似文献
75.
76.
ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. 总被引:3,自引:0,他引:3
Didier Lardinois Paul De Leyn Paul Van Schil Ramon Rami Porta David Waller Bernward Passlick Marcin Zielinski Toni Lerut Walter Weder 《European journal of cardio-thoracic surgery》2006,30(5):787-792
The European Society of Thoracic Surgeons (ESTS) organized a workshop dealing with lymph node staging in non-small cell lung cancer. The objective of this workshop was to develop guidelines for definitions and the surgical procedures of intraoperative lymph node staging, and the pathologic evaluation of resected lymph nodes in patients with non-small cell lung cancer (NSCLC). Relevant peer-reviewed publications on the subjects, the experience of the participants, and the opinion of the ESTS members contributing on line, were used to reach a consensus. Systematic nodal dissection is recommended in all cases to ensure complete resection. Lobe-specific systematic nodal dissection is acceptable for peripheral squamous T1 tumors, if hilar and interlobar nodes are negative on frozen section studies; it implies removal of, at least, three hilar and interlobar nodes and three mediastinal nodes from three stations in which the subcarinal is always included. Selected lymph node biopsies and sampling are justified to prove nodal involvement when resection is not possible. Pathologic evaluation includes all lymph nodes resected separately and those remaining in the lung specimen. Sections are done at the site of gross abnormalities. If macroscopic inspection does not detect any abnormal site, 2-mm slices of the nodes in the longitudinal plane are recommended. Routine search for micrometastases or isolated tumor cells in hematoxylin-eosin negative nodes would be desirable. Randomized controlled trials to evaluate adjuvant therapies for patients with these conditions are recommended. The adherence to these guidelines will standardize the intraoperative lymph node staging and pathologic evaluation, and improve pathologic staging, which will help decide on the best adjuvant therapy. 相似文献
77.
78.
79.
80.
Changes in snoring characteristics after 30 days of nasal continuous positive airway pressure in patients with non-apnoeic snoring: a controlled trial. 下载免费PDF全文
BACKGROUND--A study was performed to evaluate the effect of discontinuation of nasal continuous positive airway pressure (NCPAP) treatment on snoring characteristics. METHODS--Eighteen non-apnoeic snoring subjects were randomly allocated to either a no treatment control group or an NCPAP treatment group. The control group was studied twice (baseline and day 30 of follow up). In the NCPAP group the level of NCPAP that abolished snoring was determined and part abolished snoring was determined and patients were placed on NCPAP every night for one month. A sleep study was performed on the first night without NCPAP after completing 30 days of treatment (follow up 1). A fourth polysomnographic study was performed 8-10 days after NCPAP was stopped (follow up 2) in six subjects. RESULTS--In both groups total sleep time (TST) and sleep architecture remained unchanged at the different visits. Baseline snoring characteristics in the two groups were similar. In the control group the mean (SE) number of snoring episodes/hour of sleep (snoring index) and the percentage of TST > 60 decibels (dB) were 380 (36)/h and 11.1 (2.0)% TST respectively at baseline, and was unchanged at follow up. In the NCPAP group the snoring index decreased from 387 (50)/h to 320 (57)/h after NCPAP therapy, but the % TSTS > 60 dB decreased from 10.3 (1.8)% to 7.4 (1.5)%. The snoring index and intensity returned to baseline values at follow up 2 (374 (74)/h, 9.8 (2.1)% TST). Changes in snoring characteristics could not be explained by changes in body position between the different sleep studies. CONCLUSIONS--NCPAP improves snoring but this effect is lost soon after stopping treatment. 相似文献